← Open Payments lookup

KRISHAN GUPTA: Open Payments

NPI 1598769176 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$816 in 50 payments from 12 companies in 2025. Trend: 2023 $956 · 2024 $628 · 2025 $816

Food & beverage: $816
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$195
Tris Pharma Inc8$140
ABBVIE INC.10$136
Otsuka America Pharmaceutical, Inc.5$84
Supernus Pharmaceuticals, Inc.5$78
MEDICOMP INC1$40
Neurocrine BioSciences, Inc.2$36
E.R. Squibb & Sons, L.L.C.2$34
Indivior Inc.1$24
Axsome Therapeutics, Inc.1$19

Products named: FANAPT, VRAYLAR, Dyanavel XR, Qelbree, REXULTI, TELEPATCH CARDIAC MONITOR, Onyda XR, INGREZZA.

Industry payments across MS — which companies pay providers there.